Yatırımcı.AI

USUSD

Iterum Therapeutics plc

Iterum Therapeutics plc ITRMF

—
Market cap
USD 532

Key Data

USD 532
USD −7.20
Avg. volume (200d)
5.1M
Sector
Healthcare
Industry
Biotechnology

Technical Signals

Technical signals

Only our Plus members can access this area.

AI Models

AI models

Only our Plus members can access this area.

About Iterum Therapeutics Plc

Market capitalization is 532 USD, earnings per share −7.20 USD, the price-to-earnings ratio — and the dividend yield —. The company operates in the Healthcare sector, within the Biotechnology industry.

Frequently Asked Questions

Price data for ITRMF is temporarily unavailable and will refresh with the next update.

US stocks such as Iterum Therapeutics plc (ITRMF) can be bought through Turkish brokerage firms (aracı kurumlar) that offer access to foreign markets. You open an account enabled for foreign equity trading; because US stocks trade in dollars, the account and trades are in USD, so lira savings are converted to dollars first. The regular session on the NYSE and Nasdaq runs from 09:30 to 16:00 New York time, which is 16:30–23:00 Türkiye time while US daylight saving time is in effect and 17:30–00:00 otherwise. Taxation is subject to Turkish tax law; check the Revenue Administration (GİB) for current rules.

ITRMF trades at a price-to-earnings ratio of —, with earnings per share of −7.20 USD and a market capitalization of 532 USD. Ratios use the latest reported results and the current price.

The 52-week range for ITRMF cannot be calculated right now.

The current dividend yield of ITRMF is —. Dividend yield is the annual cash dividend divided by the share price; the company may change its policy.

Iterum Therapeutics plc (ITRMF) is listed on the US stock market; its sector is Healthcare and its industry is Biotechnology.

Prices, volume and fundamentals come from licensed data providers; prices are delayed by at least 15 minutes and fundamentals refresh daily. AI forecasts are generated by Yatırımcı.AI models and are not investment advice.